Evidence map›Paper›PMID 42106810›Full record

ArticleHarm reduction journal2026

A continuum of disconnection: the impacts of safer supply program closures on continuity of care, transition, and total loss of service access.

Farihah Ali, Abigale Sprakes, Jordan Mende-Gibson, Mohammad Karamouzian, Gillian Kolla, Andrew Shaw, Andrzej Celinski, Nat Kaminski, Uppala Chandresekera, Jürgen Rehm

Abstract read
In one paragraph

Article in Harm reduction journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Farihah AliInstitute for Mental Health Policy Research, Centre for Addiction and Mental Health (CAMH), 250 College Street, Toronto, ON, M5S 2S1, Canada. farihah.ontcrism@gmail.com.
Abigale SprakesFaculty of Health and Behavioural Sciences, School of Social Work, Lakehead University, 955 Oliver Road, Thunder Bay, ON, P7B 5E1, Canada.
Jordan Mende-GibsonInstitute for Mental Health Policy Research, Centre for Addiction and Mental Health (CAMH), 250 College Street, Toronto, ON, M5S 2S1, Canada.
Mohammad KaramouzianDalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
Gillian KollaFaculty of Medicine, Memorial University, St. John's, NL, Canada.
Andrew ShawInstitute for Mental Health Policy Research, Centre for Addiction and Mental Health (CAMH), 250 College Street, Toronto, ON, M5S 2S1, Canada.
Andrzej CelinskiWorkers for Ethical Substance Use Policy (WESUP), Vancouver, BC, Canada.
Nat KaminskiMoyo Health & Community Services, 7700 Hurontario St #601, Brampton, ON, L6Y 5B5, Canada.
Uppala ChandresekeraFactor-Inwentash Faculty of Social Work, University of Toronto, 246 Bloor Street West, Toronto, ON, M5S1V4, Canada.
Jürgen RehmInstitute for Mental Health Policy Research, Centre for Addiction and Mental Health (CAMH), 250 College Street, Toronto, ON, M5S 2S1, Canada.

Funding

CIHR REN- 181677CIHR REN-181677
6 · The paper itself

Abstract

objectiveIn March 2025, the expiration of federal pilot funding for Safer Supply Programs (SSPs), combined with restrictive provincial legislative changes to harm reduction service provision in Ontario, disrupted care for thousands of clients at risk of toxic drug poisoning. This study examines the impacts of these changes on client health, social stability, and overdose risk across a continuum of access.

methodWe conducted 30 semi-structured virtual interviews between September and November 2025 with clients who were enrolled in an SSP prior to March 31, 2025. Participants were recruited via purposive and snowball sampling. Data were analyzed using Braun and Clarke's reflexive thematic analysis to explore experiences across three distinct groups: those who maintained continuity with their prescriber or SSP, those who transitioned to a new prescriber or SSP, and those who lost access entirely.

resultsExperiences of harm were directly proportional to the degree of service disconnection. Participants who maintained access (n = 10) retained clinical stability, but reported chronic anxiety and "survivor's guilt" regarding peers who lost care. Participants who transitioned to an alternative prescriber (n = 13) experienced a "medicalization of harm reduction" characterized by increased surveillance (e.g., urine screens, monitored dosing), revoked take-home doses, and the loss of trusted relationships, which undermined their autonomy and stability. Those who lost access entirely (n = 7) experienced significant harms, such as the loss of an entire ecosystem of care (i.e., medication, primary care, and community), an immediate return to the unregulated fentanyl market, and engagement in survival strategies that can lead to criminalization. Notably, 100% (n = 5) of participants who reported an overdose following the policy changes belonged to this group.

conclusionThe loss of federal funding for SSPs in Ontario did not solely reduce medication availability; it severed the structural and relational network that supported participants' reintegration into health care services that they previously felt uncomfortable accessing due to stigma, surveillance and mistreatment. Findings reveal a "continuum of disconnection" where the removal of wraparound supports and the reintroduction of punitive clinical practices function as forms of structural violence. Sustainable, low-barrier models are urgently needed to prevent further morbidity and mortality.

Indexed as

Continuity of Patient CareDrug OverdoseHarm ReductionHealth Services AccessibilityNeedle-Exchange ProgramsAdultFemaleHumansMaleMiddle AgedOntarioDrug-related harmsHarm reductionOverdosePolicy changesSafer Supply Program

Identifiers

PMID42106810
PMCPMC13273957

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.